Roelke Alison Marie Form 3 SomaLogic / Alison Marie Roelke ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Roelke Alison Marie

(Last) (First) (Middle)

C/O SOMALOGIC, INC.

2945 WILDERNESS PLACE

(Street)

BOULDER CO 80301

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/21/2023

3. Issuer Name and Ticker or Trading Symbol
SomaLogic, Inc. [ SLGC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief People Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(1)	06/06/2032	Common Stock	210,157	5.71	D
Employee Stock Option (Right to Buy)	(2)	03/16/2033	Common Stock	150,000	2.3	D
Restricted Stock Unit (RSU)	(3)	(3)	Common Stock	28,507	(4)	D
Restricted Stock Unit (RSU)	(5)	(5)	Common Stock	67,000	(4)	D
Restricted Stock Unit (RSU)	(6)	(6)	Common Stock	25,000	(4)	D

Explanation of Responses:

1. The option vests as to 1/4 of the total grant on June 7, 2023, and thereafter 1/36th of the total grant vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date.

2. The option vests as to 1/4 of the total grant on March 17, 2024, and thereafter 1/36th of the total grant vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date.

3. The Restricted Stock Units ("RSUs") vest as to 1/3rd of the total grant on each of September 13, 2023, September 13, 2024 and September 13, 2025, subject to the continued service of the Reporting Person on each vesting date.

4. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.

5. The RSUs vest as to 1/4th of the total grant on each of November 9, 2023, November 9, 2024, November 9, 2025 and November 9, 2026, subject to the continued service of the Reporting Person on each vesting date.

6. The RSUs vest as to 1/4th of the total grant on each of March 17, 2024, March 17, 2025, March 17, 2026 and March 17, 2027, subject to the continued service of the Reporting Person on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Ruben Gutierrez, Attorney-in-Fact	08/18/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.